Cytonics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $929K

  • Investors
  • 5

Cytonics General Information

Description

Developer of a diagnostic therapeutics drug designed to improve the treatment of painful osteoarthritis, back, and joint pain. The company's drug offers a Fibronectin-Aggrecan Complex Test for molecular discography and a multi-analyte assay for diagnosing the source of pain in the spine and joints for identification of a naturally occurring blood protein to protect cartilage from degradation, enabling doctors to treat their patients suffering from the musculoskeletal disease.

Contact Information

Website
www.cytonics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 658 West Indiantown Road
  • Suite 214
  • Jupiter, FL 33458
  • United States
+1 (561)
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 658 West Indiantown Road
  • Suite 214
  • Jupiter, FL 33458
  • United States
+1 (561)

Cytonics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytonics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Equity Crowdfunding 27-Jun-2024 $929K Completed Generating Revenue
16. Angel (individual) Cancelled Generating Revenue
15. Equity Crowdfunding 29-May-2024 Completed Generating Revenue
14. Equity Crowdfunding Completed Pre-Clinical Trials
13. Equity Crowdfunding 22-Nov-2022 Cancelled Pre-Clinical Trials
12. Equity Crowdfunding 22-Nov-2022 Completed Pre-Clinical Trials
11. Equity Crowdfunding 01-Jan-2021 Cancelled Pre-Clinical Trials
10. Later Stage VC (Series C) 01-Apr-2020 Completed Pre-Clinical Trials
9. Later Stage VC 19-Jun-2019 $45K $19.9M Completed Pre-Clinical Trials
8. Later Stage VC $4.08M $19.8M Completed Pre-Clinical Trials
To view Cytonics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cytonics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostic therapeutics drug designed to improve the treatment of painful osteoarthritis, back, and joint
Drug Discovery
Jupiter, FL
10 As of 2024

Stockholm, Sweden
 

Jersey City, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cytonics Competitors (4)

One of Cytonics’s 4 competitors is Synartro, a Venture Capital-Backed company based in Stockholm, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Synartro Venture Capital-Backed Stockholm, Sweden
EpiBone Venture Capital-Backed Jersey City, NJ
The Binding Site Formerly PE-Backed Birmingham, United Kingdom
Ampio Pharmaceuticals Corporation Englewood, CO
To view Cytonics’s complete competitors history, request access »

Cytonics Patents

  • 61

    Total Documents Applications and Grants

  • Total Patents Families

  • 46

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Cytonics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015349782-B2 Therapeutic variant alpha-2-macroglobulin compositions Active 20-Nov-2014
AU-2015349782-A1 Therapeutic variant alpha-2-macroglobulin compositions Active 20-Nov-2014
JP-2021080282-A Therapeutic variant alpha-2-macroglobulin compositions Active 20-Nov-2014
EP-3221341-B1 Therapeutic variant alpha-2-macroglobulin compositions Active 20-Nov-2014
EP-3221341-A2 Therapeutic variant alpha-2-macroglobulin compositions Active 20-Nov-2014 C07K14/811
To view Cytonics’s complete patent history, request access »

Cytonics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytonics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
River VC Venture Capital Minority
The Rainmakers ( Application Software) Accelerator/Incubator Minority
DePuy Synthes Corporation Minority
National Institutes of Arthritis and Musculoskeletal Diseases Other
National Institutes of Neurological Disorders and Stroke Government
To view Cytonics’s complete investors history, request access »

Ready to get started?

Request a free trial

Cytonics FAQs

  • When was Cytonics founded?

    Cytonics was founded in 2006.

  • Where is Cytonics headquartered?

    Cytonics is headquartered in Jupiter, FL.

  • What is the size of Cytonics?

    Cytonics has 10 total employees.

  • What industry is Cytonics in?

    Cytonics’s primary industry is Drug Discovery.

  • Is Cytonics a private or public company?

    Cytonics is a Private company.

  • What is the current valuation of Cytonics?

    The current valuation of Cytonics is .

  • What is Cytonics’s current revenue?

    The current revenue for Cytonics is .

  • How much funding has Cytonics raised over time?

    Cytonics has raised $34.2M.

  • Who are Cytonics’s investors?

    River VC, The Rainmakers ( Application Software), DePuy Synthes, National Institutes of Arthritis and Musculoskeletal Diseases, and National Institutes of Neurological Disorders and Stroke have invested in Cytonics.

  • Who are Cytonics’s competitors?

    Synartro, EpiBone, The Binding Site, and Ampio Pharmaceuticals are competitors of Cytonics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »